ITI Life Sciences Launches First R&D Programme in Scotland o develop 3-dimensional cell-based assays
The three-year programme will take place in Scotland as a collaboration between Edinburgh Instruments Ltd, Hannah InterActions Ltd and CSS-Albachem Ltd. Initially, the programme is focused on developing instrumentation and novel cell-based screens for breast cancer, with plans to expand to other disease areas as the technology develops.
In the ITI Life Sciences programme, the three participating companies will provide complementary expertise in order to develop and commercialise fluorescence lifetime cell-based assay products, including frozen 3-D cell systems ready for screening, unique fluorescence-linked reagents and state-of-the-art optics and detection instruments. This approach brings advances in sensitivity and discrimination by using fluorescence lifetime techniques pioneered in Scotland. Three-dimensional cell culture represents an ideal model providing a much closer representation of the physiological environment than existing biochemical and cell models.
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.